JP2004516236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516236A5 JP2004516236A5 JP2001583806A JP2001583806A JP2004516236A5 JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5 JP 2001583806 A JP2001583806 A JP 2001583806A JP 2001583806 A JP2001583806 A JP 2001583806A JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- factor
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57143400A | 2000-05-15 | 2000-05-15 | |
| PCT/US2000/027438 WO2001087339A1 (en) | 2000-05-15 | 2000-10-05 | Antithrombotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516236A JP2004516236A (ja) | 2004-06-03 |
| JP2004516236A5 true JP2004516236A5 (cg-RX-API-DMAC7.html) | 2007-11-22 |
Family
ID=24283688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583806A Pending JP2004516236A (ja) | 2000-05-15 | 2000-10-05 | 抗血栓剤 |
Country Status (20)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003222020B2 (en) | 2002-03-20 | 2008-08-28 | University Of Maryland Baltimore | A non-selective cation channel in neural cells and methods for treating brain swelling |
| US8980952B2 (en) | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| JP5307397B2 (ja) * | 2004-09-18 | 2013-10-02 | ユニバーシティ オブ メリーランド，ボルチモア | ＮＣＣａ−ＡＴＰチャネルを標的とする治療剤およびその使用方法 |
| JP5085326B2 (ja) | 2004-09-18 | 2012-11-28 | ユニバーシティ オブ メリーランド，ボルチモア | ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法 |
| CA2674949A1 (en) | 2007-01-12 | 2008-07-24 | J. Marc Simard | Targeting ncca-atp channel for organ protection following ischemic episode |
| WO2009002832A2 (en) | 2007-06-22 | 2008-12-31 | University Of Maryland, Baltimore | Inhibitors of ncca-atp channels for therapy |
| RU2510400C9 (ru) | 2007-09-26 | 2014-07-20 | Чугаи Сейяку Кабусики Кайся | Способ модификации изоэлектрической точки антитела с помощью аминокислотных замен в cdr |
| DK3002298T3 (da) * | 2007-11-21 | 2019-10-28 | Univ Oregon Health & Science | Anti-faktor xi monoklonale antistoffer og fremgangsmåder til anvendelse deraf |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| US9518128B2 (en) | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
| KR102702288B1 (ko) * | 2016-12-23 | 2024-09-05 | 노파르티스 아게 | 항-인자 XI/XIa 항체를 사용한 치료 방법 |
| US20240018503A1 (en) * | 2017-04-27 | 2024-01-18 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| WO2018199214A1 (ja) | 2017-04-27 | 2018-11-01 | 中外製薬株式会社 | 薬物動態が改善された血液凝固第ｉｘ因子 |
| CN115448985A (zh) * | 2021-06-08 | 2022-12-09 | 上海循曜生物科技有限公司 | 新型抗栓抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2049655C (en) * | 1990-09-17 | 1996-11-12 | Akio Odawara | Pharmaceutical composition for inhibiting platelet aggregation |
| MA24512A1 (fr) * | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2000007626A1 (en) * | 1998-08-07 | 2000-02-17 | Smithkline Beecham Corporation | Use of anti-coagulation factor antibodies as long-lasting protective agents |
| AU766551C (en) * | 1998-08-28 | 2005-02-17 | Genentech Inc. | Human anti-factor IX/IXa antibodies |
-
2000
- 2000-10-05 JP JP2001583806A patent/JP2004516236A/ja active Pending
- 2000-10-05 CN CNB008197237A patent/CN100339132C/zh not_active Expired - Fee Related
- 2000-10-05 MX MXPA02011385A patent/MXPA02011385A/es active IP Right Grant
- 2000-10-05 EP EP06124420A patent/EP1825864A3/en active Pending
- 2000-10-05 EP EP00968710A patent/EP1282444B1/en not_active Expired - Lifetime
- 2000-10-05 NZ NZ522632A patent/NZ522632A/en unknown
- 2000-10-05 BR BR0015872-0A patent/BR0015872A/pt not_active IP Right Cessation
- 2000-10-05 AT AT00968710T patent/ATE345816T1/de not_active IP Right Cessation
- 2000-10-05 KR KR1020027015403A patent/KR20030034071A/ko not_active Ceased
- 2000-10-05 HU HU0301804A patent/HU225874B1/hu not_active IP Right Cessation
- 2000-10-05 CN CNA200710141110XA patent/CN101134107A/zh active Pending
- 2000-10-05 ES ES00968710T patent/ES2277597T3/es not_active Expired - Lifetime
- 2000-10-05 IL IL15283100A patent/IL152831A0/xx unknown
- 2000-10-05 DE DE60032029T patent/DE60032029T2/de not_active Expired - Fee Related
- 2000-10-05 CA CA002411369A patent/CA2411369A1/en not_active Abandoned
- 2000-10-05 WO PCT/US2000/027438 patent/WO2001087339A1/en not_active Ceased
- 2000-10-05 AU AU7858400A patent/AU7858400A/xx active Pending
- 2000-10-05 PL PL36006000A patent/PL360060A1/xx unknown
- 2000-10-05 AU AU2000278584A patent/AU2000278584B2/en not_active Ceased
- 2000-10-05 KR KR1020077027348A patent/KR20070116192A/ko not_active Ceased
- 2000-10-05 CZ CZ20023778A patent/CZ20023778A3/cs unknown
-
2002
- 2002-11-14 NO NO20025463A patent/NO20025463L/no not_active Application Discontinuation
- 2002-11-14 ZA ZA200209265A patent/ZA200209265B/xx unknown
-
2003
- 2003-08-11 US US10/638,777 patent/US20050037006A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516236A5 (cg-RX-API-DMAC7.html) | ||
| LU92255I2 (fr) | Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA) | |
| Lijnen et al. | Fibrinolytic agents: mechanisms of activity and pharmacology | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| WO2002095007A3 (en) | Conjugates activated by cell surface proteases and therapeutic uses thereof | |
| JP2003505343A5 (cg-RX-API-DMAC7.html) | ||
| MXPA04005755A (es) | Combinacion de inhibidores de proteasa dependientes del citocromo p450. | |
| WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
| EP1825864A3 (en) | Antithrombotic agents | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| DK1227797T3 (da) | Farmaceutiske faststofdispersionsformuleringer | |
| WO2002022107A3 (en) | Pharmaceutical composition having modified carrier | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| CA2007075A1 (en) | New thrombolytic compositions | |
| Thomson | New thrombolytic drugs | |
| MY120631A (en) | Novel pharmaceutical combination having analgesic activity | |
| JP2001521898A5 (ja) | 心筋虚血およびアンギナの処置用医薬の製造のためのキナプリルの使用 |